218 related articles for article (PubMed ID: 12086720)
1. In vitro and in vivo evaluation of Pluronic F127-based ocular delivery system for timolol maleate.
El-Kamel AH
Int J Pharm; 2002 Jul; 241(1):47-55. PubMed ID: 12086720
[TBL] [Abstract][Full Text] [Related]
2. In vitro evaluation of pluronic F127-based controlled-release ocular delivery systems for pilocarpine.
Desai SD; Blanchard J
J Pharm Sci; 1998 Feb; 87(2):226-30. PubMed ID: 9519158
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of pluronic F127-based sustained-release ocular delivery systems for pilocarpine using the albino rabbit eye model.
Desai SD; Blanchard J
J Pharm Sci; 1998 Oct; 87(10):1190-5. PubMed ID: 9758675
[TBL] [Abstract][Full Text] [Related]
4. The role of hyaluronan as a drug carrier to enhance the bioavailability of extended release ophthalmic formulations. Hyaluronan-timolol ionic complexes as a model case.
Battistini FD; Tártara LI; Boiero C; Guzmán ML; Luciani-Giaccobbe LC; Palma SD; Allemandi DA; Manzo RH; Olivera ME
Eur J Pharm Sci; 2017 Jul; 105():188-194. PubMed ID: 28506871
[TBL] [Abstract][Full Text] [Related]
5. New mucoadhesive chitosan film for ophthalmic drug delivery of timolol maleate: in vivo evaluation.
Fulgêncio Gde O; Viana FA; Ribeiro RR; Yoshida MI; Faraco AG; Cunha-Júnior Ada S
J Ocul Pharmacol Ther; 2012 Aug; 28(4):350-8. PubMed ID: 22320419
[TBL] [Abstract][Full Text] [Related]
6. Improved ocular absorption kinetics of timolol maleate loaded into a bioadhesive niosomal delivery system.
Kaur IP; Aggarwal D; Singh H; Kakkar S
Graefes Arch Clin Exp Ophthalmol; 2010 Oct; 248(10):1467-72. PubMed ID: 20437246
[TBL] [Abstract][Full Text] [Related]
7. Improvement of the ocular bioavailability of timolol by sorbic acid.
Higashiyama M; Inada K; Ohtori A; Tojo K
Int J Pharm; 2004 Mar; 272(1-2):91-8. PubMed ID: 15019072
[TBL] [Abstract][Full Text] [Related]
8. Thermo-sensitive gel in glaucoma therapy for enhanced bioavailability: In vitro characterization, in vivo pharmacokinetics and pharmacodynamics study.
Zeng Y; Chen J; Li Y; Huang J; Huang Z; Huang Y; Pan X; Wu C
Life Sci; 2018 Nov; 212():80-86. PubMed ID: 30268857
[TBL] [Abstract][Full Text] [Related]
9. Sustained ocular drug delivery from a temperature and pH triggered novel in situ gel system.
Gupta H; Jain S; Mathur R; Mishra P; Mishra AK; Velpandian T
Drug Deliv; 2007 Nov; 14(8):507-15. PubMed ID: 18027180
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of timolol in aqueous humor sampled by microdialysis after topical administration of thermosetting gels.
Wei G; Ding PT; Zheng JM; Lu WY
Biomed Chromatogr; 2006 Jan; 20(1):67-71. PubMed ID: 15954162
[TBL] [Abstract][Full Text] [Related]
11. In Situ Gelling Electrospun Ocular Films Sustain the Intraocular Pressure-Lowering Effect of Timolol Maleate: In Vitro, Ex Vivo, and Pharmacodynamic Assessment.
Andreadis II; Karavasili C; Thomas A; Komnenou A; Tzimtzimis M; Tzetzis D; Andreadis D; Bouropoulos N; Fatouros DG
Mol Pharm; 2022 Jan; 19(1):274-286. PubMed ID: 34877863
[TBL] [Abstract][Full Text] [Related]
12. Ocular Cubosome Drug Delivery System for Timolol Maleate: Preparation, Characterization, Cytotoxicity, Ex Vivo, and In Vivo Evaluation.
Huang J; Peng T; Li Y; Zhan Z; Zeng Y; Huang Y; Pan X; Wu CY; Wu C
AAPS PharmSciTech; 2017 Nov; 18(8):2919-2926. PubMed ID: 28429294
[TBL] [Abstract][Full Text] [Related]
13. Physicochemical and pharmacological investigation of water/oil microemulsion of non-selective beta blocker for treatment of glaucoma.
Hegde RR; Bhattacharya SS; Verma A; Ghosh A
Curr Eye Res; 2014 Feb; 39(2):155-63. PubMed ID: 24073659
[TBL] [Abstract][Full Text] [Related]
14. Environmentally responsive ophthalmic gel formulation of carteolol hydrochloride.
El-Kamel A; Al-Dosari H; Al-Jenoobi F
Drug Deliv; 2006; 13(1):55-9. PubMed ID: 16401594
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and intraocular pressure lowering effect of timolol preparations in rabbit eyes.
Chiang CH; Ho JI; Chen JL
J Ocul Pharmacol Ther; 1996; 12(4):471-80. PubMed ID: 8951683
[TBL] [Abstract][Full Text] [Related]
16. Bioavailability of timolol and aceclidine after ocular instillation in the rabbit.
Matera MG; Lampa E; Imperatore A; Berrino L; Russo F; Boldrini E; Rossi F
Res Commun Mol Pathol Pharmacol; 1998 Apr; 100(1):35-42. PubMed ID: 9644717
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of aqueous humor concentrations of Istalol and Betimol following a single ocular instillation in rabbit eyes.
Baklayan GA; Collins EC; Thetford T; Soriano A; Song CK; Han J
J Ocul Pharmacol Ther; 2008 Oct; 24(5):507-12. PubMed ID: 18800867
[TBL] [Abstract][Full Text] [Related]
18. Ocular pharmacokinetic/pharmacodynamic modeling for multiple anti-glaucoma drugs.
Sakanaka K; Kawazu K; Tomonari M; Kitahara T; Nakashima M; Nishida K; Nakamura J; Sasaki H; Higuchi S
Biol Pharm Bull; 2008 Aug; 31(8):1590-5. PubMed ID: 18670094
[TBL] [Abstract][Full Text] [Related]
19. Ocular poloxamer-based ciprofloxacin hydrochloride in situ forming gels.
Mansour M; Mansour S; Mortada ND; Abd Elhady SS
Drug Dev Ind Pharm; 2008 Jul; 34(7):744-52. PubMed ID: 18612913
[TBL] [Abstract][Full Text] [Related]
20. Development and evaluation of performance characteristics of timolol-loaded composite ocular films as potential delivery platforms for treatment of glaucoma.
Tighsazzadeh M; Mitchell JC; Boateng JS
Int J Pharm; 2019 Jul; 566():111-125. PubMed ID: 31129346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
